Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
10/2008
10/14/2008CA2309328C Cyclic amine derivatives and their use as drugs
10/09/2008WO2008121558A1 1, 3-thiazol-2 (3h) -ylidene compounds as cannabinoid receptor ligands
10/09/2008WO2008120754A1 Picolinamide compound
10/09/2008WO2008120099A1 Thieno [3, 2-e] [1, 2] thiazine derivative as inhibitor of carbonic anhydrase
10/09/2008US20080249146 Bicyclic antivirals for hepatitis C treatment; e.g. 1-cyclohexyl-2-phenyl-1H-thieno[3,2-d]imidazole-5-carboxylic acid
10/09/2008US20080249125 N-methyl-2-phenyl-2-{7-[2-(4-trifluoromethyl-phenyl)-ethyl]-4,7-dihydro-5H-thieno[2,3-c]pyridin-6-yl}-acetamide; sleep disorders
10/09/2008CA2681586A1 1, 3-thiazol-2 (3h) -ylidene compounds as cannabinoid receptor ligands
10/08/2008CN101282724A Pharmaceutically active tetrahydro-pyrrolo[1,2-B]isothiazole 1,1-dioxides
10/07/2008US7432375 JNK inhibitors
10/07/2008US7432287 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance
10/07/2008US7432283 Heterocyclic GABAA subtype selective receptor modulators
10/07/2008US7432278 Dicationic imidazo[1,2-a]pyridines and 5,6,7,8-tetrahydro-imidazo[1,2-a]pyridines as antiprotozoal agents
10/07/2008CA2427573C Indole derivatives as pde5-inhibitors
10/02/2008US20080242710 Controlling cell adhesion, migration, activation; antiinflammatory agents; autoimmune diseases
10/02/2008CA2677991A1 Thiazolidine derivatives
10/01/2008EP1973920A2 Process for the preparation of 5-amino-3h-thiazolo [4,5-d] pyrimidin-2-one
10/01/2008EP1973900A1 Hydantoin compounds for the treatment of inflammatory disorders
10/01/2008CN101277965A N-phenyl benzamide derivatives as sirtuin modulators
10/01/2008CN101277964A Process for preparing beta-lactamase inhibitors
10/01/2008CN101277962A Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2
10/01/2008CN100422185C Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications
10/01/2008CN100422173C Substituted pyridines and pyridazines with angiogenesis inhibiting activity
10/01/2008CN100422172C Substituted pyridines and pyridazines with angiogenesis inhibiting activity
09/2008
09/25/2008WO2008060597A3 Compounds useful as protein kinase inhibitors
09/25/2008WO2007146349A3 Cgrp receptor antagonists
09/25/2008US20080234287 Lung cancer, gastric cancer, liver cancer, leucocythemia, endometrioma, oophoroma, mammary cancer, colon cancer, prostatic cancer, or pituitary gland cancer; N (N',N'-dimethylaminoethyl)benzo[b]thieno[2,1-c]naphthalimide
09/25/2008US20080234266 Squaric Acid Derivatives II
09/24/2008EP1971611A1 Anti-viral compounds
09/24/2008EP1971602A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment
09/24/2008EP1971599A1 Antiviral 2-carboxy-thiophene compounds
09/24/2008EP1971597A2 N-(5-membered heteroaromatic ring)-amido anti-viral compounds
09/24/2008EP1971596A2 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands
09/24/2008CN101273048A Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes
09/24/2008CN101273015A 3-cyclyl-2- (4-sulfamo yl-phenyl) -N-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes
09/23/2008US7427682 Indole derivatives as selective androgen receptor modulators (SARMS)
09/23/2008US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease
09/23/2008US7427616 e.g. 8-(1-methyl-4-phenyl-1H-imidazol-5-yl)-9H-purin-6-amine9-methyl-8-(1-methyl-4-phenyl-1H-imidazol-5-yl)-9H-purin-6-amine; Tie2 receptor tyrosine kinase and angiogenesis inhibitor; diabetic retinopathy, psoriasis, cancer, rheumatoid arthritis, atheroma, Kaposi's sarcoma and haemangioma
09/23/2008CA2432872C Pyrazole compounds useful as protein kinase inhibitors
09/23/2008CA2354852C 4,5-azolo-oxindoles
09/18/2008WO2008112014A1 Methods and compositions for treating cancer
09/18/2008WO2008111473A1 Glucokinase activator
09/18/2008WO2008111300A1 Novel diamide derivative
09/18/2008WO2008111299A1 Novel diamide derivative
09/18/2008WO2008111018A2 Process for the preparation of crystals of prulifloxacin
09/18/2008WO2008111016A1 Process for the preparation of pure prulifloxacin
09/18/2008US20080227636 Isothiazolopyridin-3-Ylenamines for Combating Animal Pests
09/18/2008CA2679971A1 Glucokinase activator
09/17/2008EP1325910B1 Aliphatic nitrogenous five-membered ring compounds
09/17/2008CN101268043A Amino-alkyl-amide derivatives as CCR3 receptor ligands
09/17/2008CN101265266A Sinomenine derivative, preparation method and application thereof
09/17/2008CN101265262A New oxabispidine compounds useful in the treatment of cardiac arrhythmias
09/17/2008CN101265259A Novel IDO inhibitor and its usage method
09/17/2008CN101265254A Novel IDO inhibitor and its usage method
09/17/2008CN100418951C Cycloamine derivative and its use as medicine
09/16/2008US7425629 Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
09/16/2008US7425552 Antiviral agent especially to treat hepatitis C virus infections; 5-Hydroxy-4-(7-methoxy-1,1-dioxo-1,2-dihydro-1 lambda 6-benzo[1,2,4]thiadiazin-3-yl)-2-(3-methyl-butyl)-6-thiophen-2-yl-2H-py-ridazin-3-one; side effects reduction
09/16/2008US7425550 Lactam glycogen phosphorylase inhibitors and method of use
09/16/2008CA2515338C Inhibitors of histone deacetylase
09/11/2008US20080221131 Respiratory system disorders; asthma; chronic obstructive pulminary disease; antiproliferative agents; immunosuppressants
09/11/2008US20080221107 6-(4-chlorophenyl)-3-{4-[(3R)-3-hydroxypyrrolidin-1-yl]-3-methoxyphenyl}thieno[3,2-d][1,2,3]triazin-4(3H)-one; Melanin concentrating hormone receptor antagonist; obesity, psychiatric disorders, cognitive disorders, memory disorders, schizophrenia, epilepsy, and neurological disorders
09/10/2008EP1966222A2 Pyrazolothiazole protein kinase modulators
09/10/2008EP1966219A1 Process for the preparation of s-(+)-clopidogrel by optical resolution
09/10/2008EP1966211A1 Triazole derivatives
09/10/2008EP1486501B1 Aminomethyl-substituted thiazolobenzimidazole derivative
09/10/2008EP1323710B1 Nitrogenous five-membered ring compounds
09/10/2008CN101263146A 8-methoxy-9H-isothiazolo[5,4-B]quinoline-3,4-diones and related compounds as anti-infective agents
09/10/2008CN101263130A 2-aniline-4-aryl substituted thiazole derivatives
09/09/2008US7423034 Benzothiazine and benzothiadiazine compounds
09/04/2008WO2008105526A1 Macrocyclic compound
09/04/2008US20080214579 Thienopyrimidinediones and their use in the modulation of autoimmune disease
09/04/2008US20080214578 2R)-2-[(2-amino-5-{[(1S)-1-(2-fluorophenyl)ethyl]thio}[1,3]thiazolo[4,5-d]pyrimidin-7-yl)amino]pentan-1-ol; neurodegenerative disorders, demyelinating disease, cardio- and cerebrovascular atherosclerotic disorders, peripheral artery disease, rheumatoid arthritis, pulmonary diseases su COPD, asthma
09/04/2008CA2679126A1 Macrocyclic compound
09/03/2008EP1963329A2 Inhibitors of c-met and uses thereof
09/03/2008EP1963324A1 Heterocyclic compounds, their preparation and their use as antibacterials
09/03/2008EP1761497B1 Azadecalin glucocorticoid receptor modulators
09/03/2008CN101258152A Pyridopyrimidine derivatives as PDE4 inhibitors for the treatment of inflammatory and immune diseases
09/03/2008CN101255171A Intermediates of 2-substituted carbapenem derivatives and process for production thereof
09/02/2008US7420059 HMG-CoA reductase inhibitors and method
09/02/2008US7419993 Triazolo-epothilones
09/02/2008CA2386813C Bicyclic imidazo-3-yl amine derivatives substituted on the 6-membered ring
08/2008
08/28/2008WO2008103501A1 Compounds and methods for modulating g protein-coupled receptors
08/28/2008WO2008102908A1 Haloalkylsulfonanilide derivative
08/28/2008WO2008101665A1 Macrocyclic compounds as hcv ns3 protease inhibitors
08/28/2008WO2008081399A3 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists
08/28/2008WO2008051637A3 Pyridazinone compounds
08/28/2008CA2677843A1 Macrocyclic compounds as hcv ns3 protease inhibitors
08/28/2008CA2677706A1 Compounds and methods for modulating g protein-coupled receptors
08/27/2008EP1960343A2 Indene derivatives, their preparation and use as medicaments
08/27/2008CN101253181A Pyrido-thiazinium dyes
08/27/2008CN101253180A 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as CXC-chemokine receptor ligands
08/26/2008US7417145 Process for total synthesis of ecteinascidins and intermediates therefor
08/26/2008US7417053 Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof
08/26/2008US7417052 Phenylene derivative having tetrazole ring or thiazolidinedione ring
08/26/2008US7417041 Imidazopyrimidines as transforming growth factor (TGF) inhibitors
08/26/2008CA2532743C Intermediates for preparing dialkyl-halogenophenyl-substituted ketoenols
08/26/2008CA2432129C Pyrazole compounds useful as protein kinase inhibitors
08/21/2008WO2008099022A1 10-sulfonyl-dibenzodiazepinones useful as hepatitis c virus inhibitors
08/21/2008WO2008099019A1 6-hydroxy-dibenzodiazepinones useful as hepatitis c virus inhibitors
08/21/2008WO2007092641A3 Method for substituted 1h-imidazo[4,5-c]pyridines
08/21/2008US20080200634 Mono-,Oligo- and Polymers of Thienothiazole
1 ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 ... 152